SCHEMBL4848052

SCHEMBL4848052

COc1ccc(C(=O)C=Cc2cc(-c3ccccc3Cl)ccc2OCCN(C)C)c(F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 2/20 0.48
LMNA P02545 3/20 0.45
MEN1 O00255 2/20 0.45
HPGD P15428 2/20 0.45
KMT2A Q03164 2/20 0.45
GAA P10253 2/20 0.44
ALDH1A1 P00352 1/20 0.44
ALOX12 P18054 1/20 0.44
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
TNFRSF1A P19438 1/20 0.42
SLC6A9 P48067 3/20 0.42
MCL1 Q07820 1/20 0.41
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
ATM Q13315 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4848072 0.91 LMNA (0.48) ABCG2LMNAMEN1HPGDKMT2A
SCHEMBL4854239 0.91 SLC6A9 (0.46) ABCG2LMNAGAATNFRSF1ASLC6A9
SCHEMBL4848047 0.91 SLC6A9 (0.46) ABCG2LMNAGAATNFRSF1ASLC6A9
SCHEMBL4848487 0.91 LMNA (0.46) ABCG2LMNAMEN1HPGDKMT2A
SCHEMBL4854497 0.89 MEN1 (0.48) ABCG2LMNAMEN1HPGDKMT2A
SCHEMBL4845764 0.87 ABCG2 (0.46) ABCG2LMNAGAAPDE4APDE4B
SCHEMBL4851441 0.87 MAOB (0.54) ABCG2LMNATNFRSF1AKDM4EMAPT
SCHEMBL4846183 0.86 LMNA (0.45) ABCG2LMNAMEN1HPGDKMT2A
SCHEMBL4854790 0.86 ABCG2 (0.50) ABCG2LMNAMEN1KMT2AALDH1A1
SCHEMBL4848206 0.86 MCL1 (0.50) ABCG2MEN1KMT2ATNFRSF1ASLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed